WHO director-general is profoundly concerned after visit to Ebola outbreak area
The director-general of the World Health Organization is profoundly worried about the Ebola outbreak in the DRC, he told STAT in an interview.
Read full article →Medicare Monitor
Tracking Medicare news, policy, and coverage changes.
4 things to know about the new sunscreen ingredient the FDA approved
The Food and Drug Administration approved a new sunscreen ingredient in the U.S. for the first time in 20 years. It's been used for decades in Europe and Asia.
Read full article →Some quarantined cruise ship passengers push to return home
Some of the 18 cruise ship passengers in quarantine after a deadly hantavirus outbreak have had a tough time in isolation.
Read full article →A plan to get lifesaving food to hungry kids was working well -- until it wasn't
Through an innovative program, parents in Senegal had easy access to a therapeutic food that's a boon for malnourished kids. Now there are shortages. Health specialists say U.S. aid cuts are to blame.
Read full article →'Cool Ladies Club' is directed by 10 working-class women. They live up to the title
They gave smartphones to 10 women from a working-class Indian community to make a documentary about their unseen and unheralded lives. The results are .... pretty cool.
Read full article →COMIC: How excessive heat kills and how to stay safe
Human bodies have a natural cooling system, but it can do only so much in high temperatures and humidity. Here's the science behind how heat kills. And how to protect yourself.
Read full article →Endocrine Society Issues First Guideline on Central Precocious Puberty
(MedPage Today) -- CHICAGO -- For kids with central precocious puberty (CPP), there shouldn't be a one-size-fits-all approach to testing and treatment, according to a clinical practice guideline from the Endocrine Society. The guideline, the...
Read full article →Talquetamab Regimens Boost Survival in Multiple Myeloma
(MedPage Today) -- Talquetamab (Talvey) plus daratumumab (Darzalex) with or without pomalidomide (Pomalyst) significantly improved survival outcomes over an active regimen for relapsed or refractory multiple myeloma, a phase III trial showed....
Read full article →Screwworm spread tests US readiness after Trump staffing cuts
The U.S. spent decades driving the New World screwworm far into South America. But now the parasite has reemerged, and officials are working to beat it back yet again using many of the same tried-and-true methods as the government did in the 1950s. Experts have been tracking the path of parasitic fly as it moved steadily northward...
Read full article →Opinion: ‘I’m pretty much all in’: An interview with a woman starting medical residency at almost 73
"There are some physicians that work to 100”: Dawn Zuidgeest-Craft on becoming a medical doctor in her 70s.
Read full article →OIG: 3 Largest MA Insurers Deny Prior Auth Requests at High Rates for Long-Term Acute Care, Inpatient Rehab
An OIG report found that the three largest Medicare Advantage insurers denied prior authorization requests for long-term acute care and inpatient rehabilitation at higher rates than other MA plans in 2024. The post OIG: 3 Largest MA Insurers Deny Prior Auth Requests at High Rates for Long-Term Acute Care, Inpatient Rehab appeared first on MedCity News .
Read full article →Amgen Turns to an Independent Review to Defend Rare Disease Drug in FDA Crosshairs
FDA concerns about Amgen’s Tavneos were sparked by securities fraud litigation against ChemoCentryx, the company that originally developed the rare disease drug. The FDA wants to withdraw Tavneos’s approval, citing safety risks and alleged manipulation of the drug’s clinical trial data. The post Amgen Turns to an Independent Review to Defend Rare Disease Drug in FDA Crosshairs appeared first on MedCity News .
Read full article →